Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Mechanistic studies of Gemcitabine-loaded nanoplatforms in resistant pancreatic cancer cells

  • Anne-Laure Papa1, 3,
  • Sudipta Basu1, 3,
  • Poulomi Sengupta1, 3,
  • Deboshri Banerjee1, 3,
  • Shiladitya Sengupta1, 2, 3, 4 and
  • Rania Harfouche1, 3Email author
BMC Cancer201212:419

DOI: 10.1186/1471-2407-12-419

Received: 19 June 2012

Accepted: 20 September 2012

Published: 22 September 2012

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
19 Jun 2012 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
24 Jul 2012 Reviewed Reviewer Report - Tarun Mandal
30 Jul 2012 Reviewed Reviewer Report - Davidson Ateh
9 Aug 2012 Author responded Author comments - Rania Harfouche
Resubmission - Version 3
9 Aug 2012 Submitted Manuscript version 3
10 Aug 2012 Author responded Author comments - Rania Harfouche
Resubmission - Version 4
10 Aug 2012 Submitted Manuscript version 4
30 Aug 2012 Reviewed Reviewer Report - Davidson Ateh
14 Sep 2012 Reviewed Reviewer Report - Tarun Mandal
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
20 Sep 2012 Editorially accepted
22 Sep 2012 Article published 10.1186/1471-2407-12-419

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
BWH-HST Center for Biomedical Engineering, Harvard Medical School
(2)
Channing Laboratory, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School
(3)
MIT Division of Health Sciences and Technology, Harvard Medical School
(4)
Dana Farber Cancer Institute 450

Advertisement